Welcome To Guidepoint Qsight!

In our latest report, Guidepoint Qsight examines the growth and changing profile of male neurotoxin spending in the U.S.

“The Brotox Boom: Male Neurotoxin Spending Hits Record High” looks at how treatment volume, spending, geography, and patient demographics have shifted, including higher units per visit and a growing concentration of male spending in the West.

Built on Guidepoint Qsight Sales Measurement data from millions of transactions across thousands of U.S. medical aesthetics practices and med spas from Q1 2022 through August 1, 2026, the report offers a data-driven view of how the male aesthetics market has evolved over time.

Access "The Brotox Boom: Male Neurotoxin Spending Hits Record High"

URL
This field is for validation purposes and should be left unchanged.
Name
First Last
Email
Company
Consent*
We’d like to keep in touch. Check this box to authorize Guidepoint Qsight to contact you by email.*
CAPTCHA